Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. There is something special about the electrocardiograms (ECG) of people hospitalized with COVID-19 ...
A dynamic ECG reporting engine that supports clinical workflows with customizable components and adaptable output structures These patents strengthen AIML's position in the growing field of ...
Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG ...
Medical Advisory Board will guide clinical studies, regulatory strategy, and global adoption of AIML's AI‑driven ECG signal‑processing solutions MaxYield™ and CardioYield™ across wearables and ...
Letter of Intent: Circular Health Limited to Enhance ECG Smart Ring with AI-Powered Signal Clarity with multi‑year, per‑user SaaS license targeting commercial launch by September 2025. Global growth ...
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances ...
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership ...
AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...
Peter Kendall, Director, President & Chief Commercialization Officer, AIML"These filings represent more than technical protection-they signal our readiness to commercialize at scale. With a defensible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results